Bank Of Montreal Meridian Bioscience Inc Transaction History

Bank Of Montreal

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$31.15 - $33.39 $20,621 - $22,104	662 Added 10.75%	6,821 $226,000
Q3 2022 Nov 10, 2022	SELL	$30.9 - $33.55 $8,652 - $9,394	-280 Reduced 4.35%	6,159 $206,000
Q2 2022 Aug 11, 2022	SELL	$23.75 - $31.69 $182,993 - $244,171	-7,705 Reduced 54.48%	6,439 $202,000
Q1 2022 May 12, 2022	BUY	$19.97 - $26.94 $19,071 - $25,727	955 Added 7.24%	14,144 $383,000
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $117,156 - $145,003	-6,710 Reduced 33.72%	13,189 $268,000
Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $5,777 - $7,492	-333 Reduced 1.65%	19,899 $387,000
Q2 2021 Aug 12, 2021	BUY	$18.01 - $28.32 $364,378 - $572,970	20,232 New	20,232 $457,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.